Michael John C, Pak John, Pulido Jose, de Venecia Guillermo
Retina Institute of Illinois, Niles, Illinois 60714, USA.
Am J Ophthalmol. 2003 Jul;136(1):182-5. doi: 10.1016/s0002-9394(03)00076-x.
To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity.
Observational case series.
Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties.
In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication.
Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.
报告与过度使用具有拟交感神经活性的化合物相关的中心性浆液性脉络膜视网膜病变。
观察性病例系列。
4例患者出现中心性浆液性脉络膜视网膜病变的临床及荧光素血管造影证据。所有患者均伴有精神性应激，并大剂量摄入伪麻黄碱、羟甲唑啉或3,4-亚甲基二氧甲基苯丙胺，这些物质均具有拟交感神经特性。
在所有病例中，中心性浆液性脉络膜视网膜病变的消退与药物停用同时发生。
应告知患有中心性浆液性脉络膜视网膜病变的患者其可能与拟交感神经药物有关。
